FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4999911000001108: Lithium succinate 8% / Zinc sulphate 0.05% ointment (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
15413701000001116 Lithium succinate 8% / Zinc sulphate 0.05% ointment (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
75321701000001114 Lithium succinate 8% / Zinc sulfate 0.05% ointment en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Is a Lithium succinate + Zinc sulfate true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has active ingredient Zinc sulfate false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has active ingredient Lithium succinate false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Is a Lithium succinate + Zinc sulphate false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Is a Product containing lithium succinate and zinc sulfate false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has specific active ingredient Lithium succinate true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has specific active ingredient Zinc sulfate true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Efalith ointment (Scotia Pharmaceuticals Ltd) Is a True Lithium succinate 8% / Zinc sulphate 0.05% ointment Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Is pack of False Lithium succinate 8% / Zinc sulphate 0.05% ointment Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has VMP True Lithium succinate 8% / Zinc sulphate 0.05% ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start